UFPT Long Call Strategy

UFPT (UFP Technologies, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.

UFP Technologies, Inc. designs and custom manufactures components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics primarily for the medical market. Its single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets, which are applied in military uniform and gear components, automotive interior trim, athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. It markets and sells its products in the United States principally through a direct sales force, as well as independent manufacturer representatives. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

UFPT (UFP Technologies, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $1.70B, a trailing P/E of 24.67, a beta of 1.08 versus the broader market, a 52-week range of 173.86-274.93, average daily share volume of 224K, a public-listing history dating back to 1993, approximately 4K full-time employees. These structural characteristics shape how UFPT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.08 places UFPT roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long call on UFPT?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current UFPT snapshot

As of May 15, 2026, spot at $215.12, ATM IV 40.70%, IV rank 39.77%, expected move 11.67%. The long call on UFPT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on UFPT specifically: UFPT IV at 40.70% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 11.67% (roughly $25.10 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated UFPT expiries trade a higher absolute premium for lower per-day decay. Position sizing on UFPT should anchor to the underlying notional of $215.12 per share and to the trader's directional view on UFPT stock.

UFPT long call setup

The UFPT long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With UFPT near $215.12, the first option leg uses a $220.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed UFPT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 UFPT shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$220.00$9.00

UFPT long call risk and reward

Net Premium / Debit
-$900.00
Max Profit (per contract)
Unbounded
Max Loss (per contract)
-$900.00
Breakeven(s)
$229.00
Risk / Reward Ratio
Unbounded

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

UFPT long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on UFPT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price% From SpotP&L at Expiration
$0.01-100.0%-$900.00
$47.57-77.9%-$900.00
$95.14-55.8%-$900.00
$142.70-33.7%-$900.00
$190.26-11.6%-$900.00
$237.83+10.6%+$882.56
$285.39+32.7%+$5,638.87
$332.95+54.8%+$10,395.18
$380.51+76.9%+$15,151.49
$428.08+99.0%+$19,907.80

When traders use long call on UFPT

Long calls on UFPT express a bullish thesis with defined risk; traders use them ahead of UFPT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

UFPT thesis for this long call

The market-implied 1-standard-deviation range for UFPT extends from approximately $190.02 on the downside to $240.22 on the upside. A UFPT long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current UFPT IV rank near 39.77% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on UFPT should anchor more to the directional view and the expected-move geometry. As a Healthcare name, UFPT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to UFPT-specific events.

UFPT long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. UFPT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move UFPT alongside the broader basket even when UFPT-specific fundamentals are unchanged. Long-premium structures like a long call on UFPT are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current UFPT chain quotes before placing a trade.

Frequently asked questions

What is a long call on UFPT?
A long call on UFPT is the long call strategy applied to UFPT (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With UFPT stock trading near $215.12, the strikes shown on this page are snapped to the nearest listed UFPT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are UFPT long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the UFPT long call priced from the end-of-day chain at a 30-day expiry (ATM IV 40.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$900.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a UFPT long call?
The breakeven for the UFPT long call priced on this page is roughly $229.00 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current UFPT market-implied 1-standard-deviation expected move is approximately 11.67%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on UFPT?
Long calls on UFPT express a bullish thesis with defined risk; traders use them ahead of UFPT catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current UFPT implied volatility affect this long call?
UFPT ATM IV is at 40.70% with IV rank near 39.77%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related UFPT analysis